Commensal Neisseria species share immune suppressive mechanisms with Neisseria gonorrhoeae.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 10 02 2023
accepted: 16 03 2023
medline: 11 4 2023
entrez: 7 4 2023
pubmed: 8 4 2023
Statut: epublish

Résumé

Neisseria gonorrhoeae is a highly adapted human sexually transmitted pathogen that can cause symptomatic infections associated with localized inflammation as well as asymptomatic and subclinical infections, particularly in females. Gonococcal infection in humans does not generate an effective immune response in most cases, which contributes to both transmission of the pathogen and reinfection after treatment. Neisseria gonorrhoeae is known to evade and suppress human immune responses through a variety of mechanisms. Commensal Neisseria species that are closely related to N. gonorrhoeae, such as N. cinerea, N. lactamica, N. elongata, and N. mucosa, rarely cause disease and instead asymptomatically colonize mucosal sites for prolonged periods of time without evoking clearing immunologic responses. We have shown previously that N. gonorrhoeae inhibits the capacity of antigen-pulsed dendritic cells to induce CD4+ T cell proliferation in vitro. Much of the suppressive effects of N. gonorrhoeae on dendritic cells can be recapitulated either by outer-membrane vesicles released from the bacteria or by purified PorB, the most abundant outer-membrane protein in Neisseria gonorrhoeae. We show here that three commensal Neisseria species, N. cinerea, N. lactamica and N. mucosa, show a comparable capacity to suppress dendritic cell-induced T cell proliferation in vitro through mechanisms similar to those demonstrated previously for N. gonorrhoeae, including inhibition by purified PorB. Our findings suggest that some immune-evasive properties of pathogenic N. gonorrhoeae are shared with commensal Neisseria species and may contribute to the ability of both pathogens and commensals to cause prolonged mucosal colonization in humans.

Identifiants

pubmed: 37027389
doi: 10.1371/journal.pone.0284062
pii: PONE-D-23-03331
pmc: PMC10081783
doi:

Substances chimiques

Membrane Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0284062

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI088255
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007001
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI144180
Pays : United States

Informations de copyright

Copyright: © 2023 Zhu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Pathog. 2009 Oct;5(10):e1000629
pubmed: 19851451
J Clin Microbiol. 2006 Aug;44(8):3040-1
pubmed: 16891538
Immunol Lett. 2004 May 15;93(2-3):97-108
pubmed: 15158604
J Bacteriol. 2006 Apr;188(7):2300-8
pubmed: 16547016
Mediators Inflamm. 2013;2013:127017
pubmed: 24204097
Eur J Immunol. 2007 Nov;37 Suppl 1:S53-60
pubmed: 17972346
Vaccine. 2020 Feb 28;38(10):2396-2405
pubmed: 32037226
Cytokine. 2001 Jan 21;13(2):91-7
pubmed: 11145848
J Diabetes Metab Disord. 2020 May 1;19(1):597-604
pubmed: 32550212
EMBO J. 2002 Apr 15;21(8):1916-29
pubmed: 11953311
PLoS One. 2012;7(7):e41260
pubmed: 22844448
J Immunol. 2009 May 15;182(10):6460-9
pubmed: 19414800
Nat Rev Dis Primers. 2019 Nov 21;5(1):79
pubmed: 31754194
Mol Microbiol. 2011 Nov;82(4):976-87
pubmed: 22032638
Curr Opin Microbiol. 2008 Oct;11(5):467-71
pubmed: 18822386
Bull World Health Organ. 2019 Aug 01;97(8):548-562P
pubmed: 31384073
Infect Immun. 2012 Oct;80(10):3417-28
pubmed: 22825445
Mucosal Immunol. 2014 Jan;7(1):165-76
pubmed: 23757303
Gut. 2004 Nov;53(11):1602-9
pubmed: 15479680
Cell Host Microbe. 2012 Oct 18;12(4):509-20
pubmed: 22999859
Infect Immun. 2014 Jun;82(6):2170-9
pubmed: 24686069
Infect Immun. 2012 Nov;80(11):4014-26
pubmed: 22949553
J Immunol. 2006 Feb 15;176(4):2373-80
pubmed: 16455995
Front Immunol. 2018 Mar 19;9:455
pubmed: 29616018
Front Immunol. 2019 Feb 19;9:3187
pubmed: 30838004
Front Immunol. 2018 Dec 21;9:3044
pubmed: 30627130
Nat Rev Immunol. 2008 Jun;8(6):435-46
pubmed: 18500229
J Immunol. 2009 Feb 15;182(4):2231-40
pubmed: 19201877
Front Microbiol. 2020 Nov 12;11:575455
pubmed: 33281770
BMC Genomics. 2014 Dec 18;15:1138
pubmed: 25523208
Sex Transm Infect. 2013 Dec;89 Suppl 4:iv63-8
pubmed: 24243883
BMJ Open. 2016 Mar 14;6(3):e009629
pubmed: 26975933
J Mol Biol. 2019 Jul 26;431(16):3010-3014
pubmed: 30986425
J Clin Microbiol. 2010 Jun;48(6):2318
pubmed: 20410341
Front Immunol. 2020 Jun 19;11:1254
pubmed: 32636846
Cell Rep. 2021 Apr 27;35(4):109037
pubmed: 33910013
Annu Rev Immunol. 2012;30:1-22
pubmed: 22136168
J Biol Chem. 2018 Jul 13;293(28):11218-11229
pubmed: 29752412
J Microbiol Methods. 2009 Dec;79(3):364-6
pubmed: 19796658
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
Nat Rev Immunol. 2015 Jun;15(6):375-87
pubmed: 25976515

Auteurs

Weiyan Zhu (W)

Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Maria X Cardenas-Alvarez (MX)

Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Joshua Tomberg (J)

Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Marguerite B Little (MB)

Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Joseph A Duncan (JA)

Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Robert A Nicholas (RA)

Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH